Life Sciences

Licensees must beware of sovereign immunity following CAFC decision

Federal Circuit hands down fractured majority decision in latest dispute over rights of state entities in patent suits

Licensees must beware of sovereign immunity following CAFC decision
How compulsory patent licensing could be used to combat covid-19 in the Americas
5 Aug 2020

How compulsory patent licensing could be used to combat covid-19 in the Americas

As the race to find coronavirus cures intensifies, we explore how legislation might be deployed in Brazil, Canada, Mexico and the US to ensure inventions are shared

Patenting emerging technologies – determining how far an artisan’s knowledge goes
5 Aug 2020

Patenting emerging technologies – determining how far an artisan’s knowledge goes

A recent Federal Circuit decision and new USPTO guidance have brought a possible conflict in case law into focus

Latest

View all
4 Aug 2020

No evidence that patents are acting as a barrier to covid research, says Bristol Myers IP head

Pharma giant’s deputy general counsel Henry Hadad reflects on how work has changed during the pandemic and why more still needs to be done on 101 reform Read more

4 Aug 2020

After PTAB upholds key patent, covid-19 vaccine fight heads to court

Moderna set to face infringement battle over its mRNA-1273, a hot prospect in the fight against coronavirus Read more

1 Aug 2020

Ignore naysayers, the patent system is playing a vital role in the fight against covid-19

We have learned some important IP lessons in the months since the coronavirus pandemic surged across the world; one of which is just how crucial IP itself is to finding a way out of the crisis Read more

31 Jul 2020

Medtronic’s dual patent strategy helps keep it at the forefront of medtech innovation

The company spends a pretty penny on its own R&D efforts but also draws on external sources to fill any gaps, particularly within high-growth digital areas Read more

News

View all
27 Jul 2020

Indonesia makes compulsory licensing easier as high-tech waits on key patent reform

Country paves way for possible covid-19 vaccine order, but promised protections for technology firms are taking longer than anticipated Read more

25 Jul 2020

As IP moves up Canada’s national agenda, other countries should follow suit

Trio of initiatives shows the country means business and the risk of a global economic downturn means similar moves may also become an important part of recovery plans elsewhere Read more

20 Jul 2020

After success of early stage covid-19 vaccine trial, Oxford University's coronavirus IP policy explained

With the promising news today that a coronavirus vaccine being developed by scientists at the university is safe and triggers an immune response, we revisit our exclusive April interview with the head of Oxford's tech transfer office in which he talks about its new, expedited, approach to granting covid-related licences Read more

7 Jul 2020

A patent's journey from IAM Market to Facebook v BlackBerry

Analysis shows that assets listed on the platform sell at a higher rate than average, while they are also litigated more often Read more

Analysis

View all
31 Jul 2020

Top patent owners continue to outperform the markets, according to new analysis

Publicly-quoted companies in the IAM/ktMINE US Patent 100 enjoyed a strong June compared to their peers Read more

30 Jul 2020

China passes a major threshold in life sciences IP reform

Move to implement patent linkage is the clearest sign yet that the country is embracing pharma and biotech innovation Read more

28 Jul 2020

Merck calls for ‘democratisation’ of CRISPR-cas9 patent licensing

Simpler access to gene-editing technology needed amid ongoing IP uncertainties, say senior executives Read more

23 Jul 2020

How to price the IP rights underpinning disruptive biotech innovation

Analysts must look beyond traditional valuation methodologies to an alternative real options framework if they are to get the most bang for their buck Read more

Insights

View all
8 Jun 2020

IP Market news highlights

IAM’s biggest spring reads Read more

8 Jun 2020

From French fancy to global community – celebrating 100 issues of IAM 

Founder and editor in chief Joff Wild looks back on 17 years of IAM Read more

4 Mar 2020

IP market news highlights

A rundown of some of the top news stories on the IAM platform in December, January and February. Read more

29 Nov 2019

IP market news highlights

IAM’s biggest autumn reads Read more